Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Felix B who wrote (3003)	6/23/2020 7:50:26 PM
From: DewDiligence_on_SI	Read Replies (1) \| Respond to of 3557

The pricing restrictions are implicit, as far as I know.

To: Felix B who wrote (3003)	6/23/2020 11:59:10 PM
From: Miljenko Zuanic	1 Recommendation Recommended By CuttingEdge Bio Respond to of 3557

<What are the pricing implications with the government/BARDA funding all these Covid19 treatments? > Nor BARDA nor NIH are co-sponsor of the COVID trials: clinicaltrials.gov So far I do not see financial support? I think that Len is pissed-off that GOV gives so much $$$$ to vaccine developers and so little to treatman by Abs. He is ready to charge comercial price, or one that will generate profit to REGN (if at all cocktail is effective).